CEL-SCI Corp. (CVM)
1.62
+0.01
(+0.62%)
USD |
NYAM |
Aug 27, 16:00
1.59
-0.03
(-1.85%)
After-Hours: 19:47
CEL-SCI Enterprise Value : 29.69M for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 29.69M |
| August 25, 2026 | 27.40M |
| August 24, 2026 | 25.64M |
| August 21, 2026 | 26.35M |
| August 20, 2026 | 27.05M |
| August 19, 2026 | 30.22M |
| August 18, 2026 | 29.34M |
| August 17, 2026 | 28.63M |
| August 14, 2026 | 28.46M |
| August 13, 2026 | 27.58M |
| August 12, 2026 | 27.40M |
| August 11, 2026 | 28.11M |
| August 10, 2026 | 27.58M |
| August 07, 2026 | 31.62M |
| August 06, 2026 | 29.69M |
| August 05, 2026 | 28.11M |
| August 04, 2026 | 25.29M |
| August 03, 2026 | 23.36M |
| July 31, 2026 | 21.77M |
| July 30, 2026 | 22.83M |
| July 29, 2026 | 21.42M |
| July 28, 2026 | 22.48M |
| July 27, 2026 | 22.13M |
| July 24, 2026 | 22.13M |
| July 23, 2026 | 22.30M |
| Date | Value |
|---|---|
| July 22, 2026 | 23.01M |
| July 21, 2026 | 23.36M |
| July 20, 2026 | 23.71M |
| July 17, 2026 | 21.95M |
| July 16, 2026 | 21.60M |
| July 15, 2026 | 21.60M |
| July 14, 2026 | 21.60M |
| July 13, 2026 | 22.83M |
| July 10, 2026 | 25.64M |
| July 09, 2026 | 25.12M |
| July 08, 2026 | 26.17M |
| July 07, 2026 | 23.88M |
| July 06, 2026 | 23.71M |
| July 02, 2026 | 21.42M |
| July 01, 2026 | 19.84M |
| June 30, 2026 | 19.66M |
| June 29, 2026 | 15.79M |
| June 26, 2026 | 16.05M |
| June 25, 2026 | 14.90M |
| June 24, 2026 | 15.07M |
| June 23, 2026 | 15.28M |
| June 22, 2026 | 15.20M |
| June 18, 2026 | 15.45M |
| June 17, 2026 | 15.96M |
| June 16, 2026 | 15.20M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 616.24M |
| Amgen, Inc. | 281.36B |
| Anika Therapeutics, Inc. | 276.98M |
| BioCryst Pharmaceuticals, Inc. | 2.993B |
| Imunon, Inc. | 8.586M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.668M |
| Total Expenses (Quarterly) | 5.668M |
| EPS Diluted (Quarterly) | -0.4678 |
| Earnings Yield | -159.4% |
| Normalized Earnings Yield | -159.51 |